Mašič LP - Search Results

1

Synthesis, Antiproliferative Effect, and Topoisomerase II Inhibitory Activity of 3-Methyl-2-phenyl-1H-indoles.

Zidar N, Secci D, Tomašič T, Mašič LP, Kikelj D, Passarella D, Argaez ANG, Hyeraci M, Dalla Via L. Zidar N, et al. Among authors: masic lp. ACS Med Chem Lett. 2020 Jan 24;11(5):691-697. doi: 10.1021/acsmedchemlett.9b00557. eCollection 2020 May 14. ACS Med Chem Lett. 2020. PMID: 32435372 Free PMC article.

2

Novel pyrazinone and pyridinone thrombin inhibitors incorporating weakly basic heterobicyclic P(1)-arginine mimetics.

Kranjc A, Masic LP, Reven S, Mikic K, Prezelj A, Stegnar M, Kikelj D. Kranjc A, et al. Among authors: masic lp. Eur J Med Chem. 2005 Aug;40(8):782-91. doi: 10.1016/j.ejmech.2005.03.007. Eur J Med Chem. 2005. PMID: 15890436

3

Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.

Sink R, Kovac A, Tomasić T, Rupnik V, Boniface A, Bostock J, Chopra I, Blanot D, Masic LP, Gobec S, Zega A. Sink R, et al. Among authors: masic lp. ChemMedChem. 2008 Sep;3(9):1362-70. doi: 10.1002/cmdc.200800087. ChemMedChem. 2008. PMID: 18651694

4

Synthesis and biological evaluation of new glutamic acid-based inhibitors of MurD ligase.

Tomasić T, Zidar N, Rupnik V, Kovac A, Blanot D, Gobec S, Kikelj D, Masic LP. Tomasić T, et al. Among authors: masic lp. Bioorg Med Chem Lett. 2009 Jan 1;19(1):153-7. doi: 10.1016/j.bmcl.2008.10.129. Epub 2008 Nov 5. Bioorg Med Chem Lett. 2009. PMID: 19014883

5

Rhodanine as a privileged scaffold in drug discovery.

Tomasić T, Masic LP. Tomasić T, et al. Among authors: masic lp. Curr Med Chem. 2009;16(13):1596-629. doi: 10.2174/092986709788186200. Curr Med Chem. 2009. PMID: 19442136 Review.

6

Synthesis and antibacterial activity of 5-ylidenethiazolidin-4-ones and 5-benzylidene-4,6-pyrimidinediones.

Tomasić T, Zidar N, Mueller-Premru M, Kikelj D, Masic LP. Tomasić T, et al. Among authors: masic lp. Eur J Med Chem. 2010 Apr;45(4):1667-72. doi: 10.1016/j.ejmech.2009.12.030. Epub 2009 Dec 22. Eur J Med Chem. 2010. PMID: 20060624

7

ATP-binding site of bacterial enzymes as a target for antibacterial drug design.

Škedelj V, Tomašić T, Mašič LP, Zega A. Škedelj V, et al. Among authors: masic lp. J Med Chem. 2011 Feb 24;54(4):915-29. doi: 10.1021/jm101121s. Epub 2011 Jan 14. J Med Chem. 2011. PMID: 21235241 Review. No abstract available.

8

Structure-based design of a new series of D-glutamic acid based inhibitors of bacterial UDP-N-acetylmuramoyl-L-alanine:D-glutamate ligase (MurD).

Tomasić T, Zidar N, Sink R, Kovac A, Blanot D, Contreras-Martel C, Dessen A, Müller-Premru M, Zega A, Gobec S, Kikelj D, Masic LP. Tomasić T, et al. Among authors: masic lp. J Med Chem. 2011 Jul 14;54(13):4600-10. doi: 10.1021/jm2002525. Epub 2011 Jun 3. J Med Chem. 2011. PMID: 21591605

9

Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.

Tomašić T, Kovač A, Klebe G, Blanot D, Gobec S, Kikelj D, Mašič LP. Tomašić T, et al. Among authors: masic lp. J Mol Model. 2012 Mar;18(3):1063-72. doi: 10.1007/s00894-011-1139-8. Epub 2011 Jun 12. J Mol Model. 2012. PMID: 21667288

10

New 5-benzylidenethiazolidin-4-one inhibitors of bacterial MurD ligase: design, synthesis, crystal structures, and biological evaluation.

Zidar N, Tomašić T, Šink R, Kovač A, Patin D, Blanot D, Contreras-Martel C, Dessen A, Premru MM, Zega A, Gobec S, Mašič LP, Kikelj D. Zidar N, et al. Among authors: masic lp. Eur J Med Chem. 2011 Nov;46(11):5512-23. doi: 10.1016/j.ejmech.2011.09.017. Epub 2011 Sep 17. Eur J Med Chem. 2011. PMID: 21963114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters